The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ

Clin Oncol (R Coll Radiol). 2015 Jan;27(1):6-8. doi: 10.1016/j.clon.2014.09.015. Epub 2014 Nov 3.

Authors

A Francis¹, L Fallowfield², D Rea³

Affiliations

¹ Breast Surgery Department, Nuffield House Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, Birmingham, UK. Electronic address: [email protected].
² Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
³ Clinical Trials Unit (CRCTU), School of Cancer Sciences, University of Birmingham, Birmingham, UK.

PMID: 25445552
DOI: 10.1016/j.clon.2014.09.015

No abstract available

Publication types

Editorial

MeSH terms

Breast Neoplasms / diagnosis*
Breast Neoplasms / surgery
Breast Neoplasms / therapy*
Carcinoma, Intraductal, Noninfiltrating / diagnosis*
Carcinoma, Intraductal, Noninfiltrating / surgery
Carcinoma, Intraductal, Noninfiltrating / therapy*
Female
Humans
Mammography / adverse effects
Mammography / methods
Mass Screening / adverse effects
Mass Screening / methods